chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive / covid test result=Positive; tested positive / covid test result=Positive; Mild cold symptoms; lost taste and smell; lost taste and smell; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 18 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 27Oct2021 (Lot number: EF2593) at the age of 18 years as dose 3, booster for covid-19 immunisation. Relevant medical history included: "Autoimmune-Hashimoto" (unspecified if ongoing); "Juvenile idiopathc arthritis" (unspecified if ongoing); "DGBI" (unspecified if ongoing); "known allergies; Bees" (unspecified if ongoing). Concomitant medication(s) included: TOCILIZUMAB; CELEBREX; CYMBALTA. Past drug history included: Enbrel, reaction(s): "known allergies;Enbrel". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EM9809, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 09Apr2021, when the patient was 17 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EM9810, Location of injection: Arm Right, Route of Administration: Intramuscular), administration date: 19Mar2021, when the patient was 17 years old, for Covid-19 Immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 18Mar2022, outcome "recovered with sequelae" and all described as "tested positive / covid test result=Positive"; NASOPHARYNGITIS (non-serious) with onset 18Mar2022, outcome "recovered with sequelae", described as "Mild cold symptoms"; AGEUSIA (non-serious), ANOSMIA (non-serious) all with onset 18Mar2022, outcome "recovered with sequelae" and all described as "lost taste and smell". The patient underwent the following laboratory tests and procedures: sars-cov-2 test positive: (23Mar2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19, nasopharyngitis, ageusia, anosmia.  Clinical Course: Facility type vaccine: Pharmacy. Post vaccination COVID test was performed.  No follow-up attempts are possible. No further information is expected.
No adverse event; Bivalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 41-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent doses administered after the BUD to patients).    Concomitant medication was not reported. Treatment medication was not reported.
Patient stated that she had not had her COVID-19 shot yet and asked pharmacist to vaccinate her. She indicated on the consent form that she had not had the same vaccine before. The pharmacist was not able to log on to the state immunization registry before administering the vaccine. Another pharmacist later was able to access the state immunization registry which indicated that the patient received the first Moderna dose  1/29/2021 and the second dose 2/26/21.
Patient refer that she feels itchy. She started to have red skin by the neck. Pharmacist administered Benadryl 50mg capsule by mouth.  Patient refer minutes later she was not feeling well yet, she decide to go to hospital with the emergency personnel.
NOSE BLEEDS; PAIN AT SITE OF INJECTION; SHARP PAIN IN THE HEAD/HEADACHE; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known drug allergies. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 0428218, and expiry: unknown) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced pain at site of injection. On APR-2021, the subject experienced sharp pain in the head. On 21-APR-2021, the subject experienced nose bleeds. The action taken with covid-19 vaccine  was not applicable. The patient recovered from pain at site of injection on 2021, and had not recovered from nose bleeds, and sharp pain in the head. This report was non-serious.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 with a home test on 08/14/2022. My symptoms where sore throat, chills and fever. I contacted my doctor and they prescribed PAXLOVID and I could not take it because it made be nauseated. I went the emergency room because I was dehydrated and received fluids. They gave me something for the sore throat and nausea. I started feeling better.
from the patient   I was offered the shingles vaccine on Thursday. I always knew I'd get one bc my mom got shingles. It was an awful experience and I had no idea that there were going to be side effects. I did no research, which was dumb on my part. So, with no questions or more info, I got the shot at about 10 am on Thursday. I started to feel different that evening with tired muscles which usually means I'm getting sick. I felt agitated at bedtime about 12 hours later. about 14 hours after the shot,  I awoke out of a sound sleep with electric shock type feelings in my stomach (the feeling you get if you are looking down at something when someone slams on the breaks - the surge of anxiety you get all at once). When I stood up, I felt like I'd been hit by a train.  I guess you'd say flu-like symptoms. My arm was swollen and super sore too. I was sick for two days and super tired on the third. I felt exhausted again last night. I am telling you all this in case it is supposed to be reported (CDC?) or putting in my record or something. That was horrible and I'm am not looking forward to the second shot!! Should I even get it if it made me sick?
Injection site pain; Fatigue; fever; chills; headache; body aches; Nausea; vomiting; This is a spontaneous report from a contactable nurse, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 14Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021, the patient experienced injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events injection site pain, fatigue, fever, chills, headache, body aches, nausea, vomiting was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Client stated that this was their first COVID-19 vaccine and wanted a Novavax. Database was down /unavailable.  When manually entering the information in database the next day, it was found that the client had in fact already received three Moderna COVID-19 vaccines.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 01-OCT-2011, a health care provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2012, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the zoster vaccine live (ZOSTAVAX) vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
My child developed MISC after receiving her first does of the Pfizer Covid vaccine. She was hospitalized for a week with severe symptoms. She received IVIG and steroid treatment at the hospital and is on daily aspirin for risk of blood clotting. Many of her organs were impacted and we have a long road to recovery.   Patient was admitted on 3/1/2022 with a high fever and abdominal inflammation evidenced by ultrasound and CT scans of her abdomen. She had tachycardia for days, had bloodshot eyes and a full body rash. She had severe back and neck pain and was unable to walk. She was weak in her extremities from joint and tendon inflammation. She was in a lot of pain as her body was trying to regulate the reaction to the Covid vaccine.
Bruising and mild pain at administration site, two days later redness had spread about three inches in diameter, it feels like a welt, itchy, pain had increased, still a bruise at administration site.
Day 1 extremely tired. Day 2 weak with flu like symptoms Day 3 moderate fever, weak mild headache, with nausea, threw up twice. Day 4 worst with chills and fever around 100 degrees. Sweating with chills. Called the medical centers emergency room and spoke to a Dr. about the side effects. He evaluated my complete medical history and clearly stated that I could go to the emergency room at anytime but recommend to wait one or two more days, I should experience recovery.
A non-serious spontaneous report of vomiting has been received from a consumer concerning a four-year-old male subsequent to FLUMIST.  This case is submitted in accordance with MedImmune's post-marketing commitment on accelerated reporting for the newly indicated population of 2 years to 59 months of age for FLUMIST.  Medical history and concomitant medications were not provided.  On 10-Nov-2008, the patient received FLUMIST.  Forty minutes after receiving FLUMIST, the patient "threw up"/experienced vomiting.  The outcome of the event was not reported.
Patient complains of extreme pain (cannot sleep), pain upon touching that radiates to elbow, all day and night.
Interchange of vaccine product; minor redness; swelling; local inflammatory story; allergies and drug reactions; This is a spontaneous report received from contactable reporter(s) (Physician and Pharmacist). Other Case identifier(s): MOD22-029002 (Moderna).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE NUMBER UNKNOWN, SINGLE, unknown manufacturer), for COVID-19 immunization; Moderna (DOSE 1, SINGLE), for COVID-19 immunization.  The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown", described as "Interchange of vaccine product"; ERYTHEMA (non-serious), outcome "unknown", described as "minor redness"; SWELLING (non-serious), outcome "recovering"; INFLAMMATION (non-serious), outcome "unknown", described as "local inflammatory story"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "allergies and drug reactions".  Additional information: I am a retired physician and called Moderna to get some background info on inert ingredients as my wife had a minor redness and swelling to the new bivalent Pfizer covid vaccine, but had no such reaction to Moderna in the past-although did have some moderate symptoms with the first dose of Modema. The symptoms she had and mine are well known, minor and fairly common with many other vaccines especially flu vaccine. As a courtesy, I provided the requested information for what I would not normally consider a reportable condition-common mild symptom written in the literature. I called Moderna after my wife received a bivalent booster. My wife has a lot of allergies and drug reactions, and she had a local inflammatory story issue with the Pfizer bivalent And just to give you a kind of reference point. She was recently given a generic Statin drug. And she had a allergic reaction to it. And I feel that in that case, and her allergic reaction was not to the statin because shes now on another statin. But theres something you know one of the in their ingredients and that particular manufacturer So I was just trying to compare the ingredients and the Pfizer bivalent versus the Moderna bivalent because we have had Moderna before. Alright, But this time we were only able to get the Pfizer so we took it. But I do not consider fatigue, mild aches and pains and mild, feverish reaction, which are well reported with many vaccines. To be side effects. Yes, I know they are sort of effects. It just happened that I had to be a physician calling and it happened to be in my family.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever (100.2), chills, body aches, headache,  nausea. Chills lasted about 6 hours, other symptoms lingered for 4 days.
This spontaneous report was received from a licensed nurse practitioner refers to an unspecified number of patients of unknown age and gender. The nurse reported that unspecified number of improperly stored PROQUAD (Merck) doses have been administered to unspecified number of patients on unspecified dates. The vaccines had been stored at -10 C (Celsius) (above recommended temperature range in product information) since July 2013. No adverse effects reported. This is one of two reports. The case is linked to (same reporter link). Additional information has been requested.
The client complains about itch at the injection site. Soon complained about the spread of itching in both her arms.  We observed red spots on her arms too. The patient was administered Benadryl 50mg/1.0mL IM on right Deltoid. The itchiness was relieved. Patient felt dizzy at 11:13 am, vital signs stable. Legs elevated.  Patient symptoms subsided.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 2 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; janssen coviD-19 vaccine (JANSSEN COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The patient had no known allergies. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Treatment included Paxlovid (Treatment start date: 21Jun2022, Treatment stop date: 26Jun2022).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
28MAY94 & 29JUN94 low grade temp/fussy; 30JUN94 130AM-430AM awake & fussy; 8AM screaming like cry that lasted all day & until about 8-9PM; t100.5;
11 day p/vax pt began w/rash over trunk & low grade fever; 2 Kopliks spots were noted;
Area of redness and warm to touch approx 3"x5" Left deltoid. Ice/TYLENOL
On 4/09/2015 patient informed pharmacist of ear and neck pain. Also neck stiffness beginning approximately 3 hours after immunizations. Patient indicated he was taking anti-inflammatory medication for the discomfort. On 4/10/2015 and 4/14/2015 patient indicated he was doing better but not yet without symptoms. On 04/14/2015 pharmacist advised patient to return to nurse practioner for evaluation. Pharmacist spoke with patient on 4/16/2015. Patient indicated that he had returned and they indicated to him that they did not believe that it was vaccine related.
Swelling of left arm that currently has had lymphedema and has been under control for over 20 years.  Still swollen. This happened after first shot. After second shot on Wed. Evening, I felt a bit achy by bedtime. On the next day, 25th, I was extremely achy, ran low fever, and had difficulty with swollen and painful lymph nodes in my right arm. Friday, I was feeling better but still painful arm and lymph nodes. .
12 mo received immunizations (Preona #4 Hep A + VARIVAX) then developed raised red itchy rash 5/7/09. No fever, illness or fussiness.
A little bit of aching; Sore throat; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (A little bit of aching), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced PAIN (A little bit of aching), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 04-Mar-2021, OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Headache) had resolved. At the time of the report, PAIN (A little bit of aching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included high blood pressure medication.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received: Contain Non- significant information
Was monitored for half hour, went out to car, felt nauseous, vomited x1, initially vitals were stable, felt weak, 02 sat dropped to high 70's, pulse was elevated, respiratory rate increased to mid 30's, given IM Benadryl and epi-pen, became unresponsive.  Went to ED for observation-was given anti nausea medication.  Sent home same day.
pt recvd vax; purple around mouth; no oth sxs;pt fine on 17mar95;mouth slightly discolored;
I am 8 years post menopausal and on estrogen /progesterone for menopausal symptoms.  Develop bleeding post 2 nd covid vaccine. Went to GYN and stopped hormones to check biopsy and US for cause.  Still waiting.  Bleeding did stop after stopping hormones
Got covid vaccines in January 2022 and later acquired COVID in February. Since 3/13/22, much increase in seizure frequency from baseline of about 3 seizures per month to about 15 seizures per month. Has even had Todd's paralysis due to the seizures in addition. VNS is not helping these seizures.
About 2 weeks after receiving it, in the afternoon/evening, I got extremely dizzy. I had to lay down; everything was spinning. I had to rest on the couch the entire night. I didn't know what it was from. I didn't have any other symptoms. I thought maybe I was coming down with something. I went to bed. I  then dealt with dizziness for two or three weeks after that - I would be slightly dizzy on and off. It came and went. I had trouble breathing. At times, I felt like I couldn't get enough air in. I'm a teacher and I would feel sometimes like I would have to stop to get more air to talk - and at that moment I would be having some slight dizziness, too. I had to be calm and focus on breathing. For about 2 months and during that time, my head felt funny. It was like pressure on the top and back of my head. It wasn't a headache. It was slight pressure on the top and back of my head and that happened for a month or two. It's only been two weeks since I haven't had that. Today I saw my doctor and I don't have any of those symptoms anymore.
About 10 days after second vaccine, pt developed itching on her palms and feet.  They became red.  After another 4-5 days the patient complained of burning of both hands and feet.  Pt given oral prednisone and tried multiple otc remedies.
At time of injection I felt severe pain as if something was tearing inside at the injection site.  The site was very painful and turned red, hot, and swollen on the first day.  The redness progressed daily and it felt like I had lumps spreading out that were painful.  This continued and I went to see the doctor after 2 weeks as it was not getting better.  She examined and felt a hematoma.  It was painful and she was worried about streaks and put me on Clindamycin HCL 300 MG capsule by mouth 4 times a day for 10 days.  She drew with a marker around the area that was red, bruised, and swollen and told me to call her right away if it continued to spread beyond the area where she drew. She also told me to put some warm compresses on to help dissolve the hematoma that had formed.  It has only been two days since I saw her and started taking the antibiotics.  The arm is still  painful and the lump is still there.
Initial nurse report received on 20 Jul 2010: This patient received MENVEO (batch number: 100022, expiration date Apr 2012), 0.5 ml intramuscularly on an unknown date. It was reported that the patient inadvertently received 0.5 ml dose of only the liquid conjugate component of MENVEO instead of being reconstituted with Men A component. The outcome of the event was not reported. The causality was not reported.
pt recv vax 24JUN92 & 27JUN92 exp bad flu sx & fatigue;devel arthritis for 1mo which was so severe that had trouble getting out of bed to go to work;exp earache & had vertigo;devel severe tooth & jaw pain in 1993;